| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/24/1998 | US5721271 Parasiticidal milbemycin derivatives |
| 02/24/1998 | US5721137 Stable synthetic promoter which controlls expression of a heterologous gene in escherichia and bacillus |
| 02/24/1998 | US5721132 Synthetic gene for D4 dopamine receptors |
| 02/24/1998 | US5721130 Monitoring alzheimer's disease |
| 02/24/1998 | US5721128 Process for the production of novel pullulanase |
| 02/24/1998 | US5721127 Isolated from bacillus deramificans |
| 02/24/1998 | US5721126 Method for cloning and producing the SCaI restriction endonuclease in E. coli |
| 02/24/1998 | US5721114 Cultivating a transformed escherichia strain in culture medium, inducing expression of apolipoprotein a1-m protein of specific amino acid sequence in logarithmic growth phase before stationary phase is attained, separating the product |
| 02/24/1998 | US5721110 Reacting autoimmune antigen (from genetically engineered cells) with autoimmune antibody(from test sample) to form a complex which can be identified |
| 02/24/1998 | US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis |
| 02/24/1998 | US5721104 Screening assay for anti-HIV drugs |
| 02/24/1998 | US5720959 Malaria vaccine |
| 02/24/1998 | US5720957 Recombinant human cytomegalovirus vaccine |
| 02/24/1998 | US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor |
| 02/24/1998 | US5720936 Screening compounds for effect on alzheimer*s disease by administering to transgenic mouse bearing nucleic acid construct coding for amyloid precursor protein, determining altered expression or processing of said protein |
| 02/24/1998 | CA2131317C Test for helicobacter pylori |
| 02/19/1998 | WO1998006867A1 A new method for producing pravastatin precursor, ml-236b |
| 02/19/1998 | WO1998006857A1 Plant tissue treatment composition |
| 02/19/1998 | WO1998006856A1 Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use |
| 02/19/1998 | WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS |
| 02/19/1998 | WO1998006845A1 Mammalian ribonuclease inhibitors and use thereof |
| 02/19/1998 | WO1998006838A1 Methods and means for modifying complement activation |
| 02/19/1998 | WO1998006830A1 Synthetic polynucleotides |
| 02/19/1998 | WO1998006748A1 Acquired resistance npr genes and uses thereof |
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
| 02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | WO1998006420A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | WO1998002567A3 PROCESS FOR THE PREPARATION OF CEPHALOSPORINS USING $i(ACREMONIUM CHRYSOGENUM) |
| 02/19/1998 | WO1998001568A3 Method of preparing (s) - or (r) -3,3,3-trifluoro-2-hydroxy-2- methylpropionic acid |
| 02/19/1998 | WO1997049805A3 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |
| 02/19/1998 | CA2263792A1 Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use |
| 02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | CA2263219A1 Methods and means for modifying complement activation |
| 02/19/1998 | CA2263146A1 Acquired resistance npr genes and uses thereof |
| 02/19/1998 | CA2262524A1 Gnrh-leukotoxin chimeras |
| 02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 02/19/1998 | CA2261572A1 Lysyl oxidase synthetic polynucleotides |
| 02/19/1998 | CA2213285A1 Novel polyene antibiotics, 3874 h1 to h6, processes for their preparation and use |
| 02/18/1998 | EP0824148A2 Polyester synthase gene and process for producing polyester |
| 02/18/1998 | EP0675900B1 Antibiotics ge 37468 a, b and c |
| 02/18/1998 | CN1173897A Eukaryotic initiation factor SA (eif-5A) mutants |
| 02/18/1998 | CN1173895A Bacillus proteases |
| 02/18/1998 | CN1173894A Bacillus Proteases |
| 02/18/1998 | CN1173877A Novel membrane proteins of helicobacter pylori |
| 02/17/1998 | US5719127 Modified complement system regulators |
| 02/17/1998 | US5719121 Administering balhimycin to monogastric or polygastric animal as growth promoter |
| 02/17/1998 | US5719052 Device comprising metering suction pump, gas detection tube containing reagent for detection of ammonia and organic amines, throat or larynx stimulating member |
| 02/17/1998 | US5719048 Adjusting ph of low ionic strength solution to about the pi of enzyme of interest; crystallization |
| 02/17/1998 | US5719045 Process for preparing nicotinamide |
| 02/17/1998 | US5719044 Complexing |
| 02/17/1998 | US5719030 Monoclonal antibody to prostate-derived acid phosphatase and method for determination of acid phosphatase using the same as well as kit for determination |
| 02/17/1998 | US5719020 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens |
| 02/17/1998 | US5718898 Monoclonal antibody or fragment thereof which specifically binds to gp200 of saccharomyces sensu stricto, but does not cross-react with any other species of yeast |
| 02/17/1998 | US5718897 Contacting with purified clostridiopeptidase a collagenase and a growth factor to increase effects of collagenase |
| 02/16/1998 | CA2213104A1 Novel purine nucleosidase |
| 02/12/1998 | WO1998005768A1 Improved nucleic acids encoding a chimeric glycosyltransferase |
| 02/12/1998 | WO1998005765A1 Double-stranded dna with cohesive end(s), and method of shuffling dna using the same |
| 02/12/1998 | WO1998005764A1 Nucleic acid pool and method for producing the same |
| 02/12/1998 | WO1998005687A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 02/12/1998 | WO1998005343A1 Anti-stress drugs and functional foods having anti-stress effects |
| 02/12/1998 | WO1998005199A1 Shoot meristem specific promoter sequences |
| 02/12/1998 | CA2262780A1 Shoot meristem specific promoter sequences |
| 02/12/1998 | CA2233705A1 Improved nucleic acids encoding a chimeric glycosyltransferase |
| 02/11/1998 | EP0823485A1 Process for amplification of Neisseria gonorrhoeae nucleic acid sequences |
| 02/11/1998 | EP0823484A1 Materials and methods for species-specific detection of mycobacterium kansasii nucleic acids |
| 02/11/1998 | EP0823479A2 Modified thermostable DNA polymerase |
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0823438A2 Human mucin cone protein: peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 02/11/1998 | EP0822988A2 Recombinant preduodenal lipases and polypeptide derivatives produced by plants, processes for obtaining them and their uses |
| 02/11/1998 | EP0822987A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
| 02/11/1998 | EP0822982A1 Cyclomaltodextrin glucanotransferase variants |
| 02/11/1998 | EP0822981A1 Enzymatic production of halogenated cephalosporin |
| 02/11/1998 | EP0822980A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 02/11/1998 | EP0822834A1 Recombinant (beta)-cell and uses thereof |
| 02/11/1998 | EP0822832A1 Cd45rb binding compounds for the prevention of transplant rejection |
| 02/11/1998 | EP0667909B1 Biotechnological method of producing biotin |
| 02/11/1998 | EP0500734B1 Protein complexes having factor viii:c activity and production thereof |
| 02/11/1998 | CN1173206A Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |
| 02/11/1998 | CN1173205A Municipal solid waste processing facility and commercial lactic acid production process |
| 02/11/1998 | CN1173204A Immunogens for stimulating mucosal immunity |
| 02/11/1998 | CN1173182A Novel Polypeptides |
| 02/10/1998 | US5717129 Methods for maintaining sterility in plants |
| 02/10/1998 | US5717084 Genetic engineered dna sequence obtained from gene expression from plant under control of the promoter |
| 02/10/1998 | US5717074 Macrophage-derived inflammatory mediator (MIP-2) |
| 02/10/1998 | US5717072 For suppressing immune or inflammatory response in mammals |
| 02/10/1998 | US5717071 Culture product bactericide specific binding to lipopolysaccharide of outer membrane for treating bacterial infection |
| 02/10/1998 | US5717069 Insecticide |
| 02/10/1998 | US5716934 Eck receptor ligands |
| 02/10/1998 | US5716930 Polypeptide from genetically engineered cells |
| 02/10/1998 | US5716841 Process for the resolution of ethyl 4,4,4-trifluoro-3(R)-hydroxybutanoate using lipase from candida |
| 02/10/1998 | US5716838 Culture of microorganisms such as rhizobium, arthrobacter |
| 02/10/1998 | US5716837 Expression of sucrose phosphorylase in plants |
| 02/10/1998 | US5716836 Anti-sulfated tyrosine antibody specific for sulfated tyrosine, process for producing the same, and hybridoma capable of producing anti-sulfated tyrosine monoclonal antibody specific for sulfated tyrosine |
| 02/10/1998 | US5716820 Fumonisin detoxification enzymes |
| 02/10/1998 | US5716815 Method for preparing dimethylcarboxylic acid compounds |
| 02/10/1998 | US5716799 Qualitative colorimetric analysis |
| 02/10/1998 | US5716793 Immunocomplexing |